Multifunctional roles of homeobox gene DLX4 in ovarian cancer

描述(申请人提供)：70%被诊断为上皮性卵巢癌(EOC)的妇女患有晚期疾病，很少能通过手术和常规化疗治愈。了解卵巢癌的分子发病机制对于识别更准确的标志物以改进早期检测以及针对癌症特异性分子变化进行新一代靶向治疗至关重要。我们的目标是确定新的分子焦点，以控制驱动卵巢癌发病的多条途径。许多驱动肿瘤发病的途径是控制正常胚胎发育的过程的异常。我们发现同源异型盒基因DLX4在正常卵巢和良性卵巢囊肿中不表达，而在恶性卵巢癌中的表达与腹水、高级别肿瘤和晚期疾病密切相关。我们对异种移植模型的研究表明，DLX4促进了EOC的生长、播散、血管形成和腹水。我们假设DLX4是一个分子焦点，通过诱导促血管生成和转移程序促进卵巢癌的发病。该建议的目的是确定DLX4作为分子开关诱导EOC发病机制中的效应分子表达的机制。我们的具体目标是确定：1)DLX4控制关键促血管生成和转移因子表达的调控水平2)DLX4重新编程基因表达的一种新的调节机制3)这种重新编程机制的临床意义和预后相关性在其任务和影响中，本建议解决了EOC生物学基础研究的基本需求。此外，在研究模式基因在肿瘤发病机制中的新调控机制方面，这项研究提供了关于癌症如何与胚胎发育密切相关的关键见解。 公共卫生相关性：这项建议是针对上皮性卵巢癌的研究，这是一种人们知之甚少的疾病，其特点是侵袭性传播，是女性癌症死亡的第五大原因。我们将研究上皮性卵巢癌中胚胎模式基因的解除调控促进肿瘤生长、扩散、血管生成和腹水的新机制。

DESCRIPTION (provided by applicant): Seventy percent of women who are diagnosed with epithelial ovarian cancer (EOC) present with advanced- stage disease and are rarely cured by surgery and conventional chemotherapy. Understanding the molecular pathogenesis of EOC is essential to identify more accurate markers to improve early detection, and cancer- specific molecular alterations against which new-generation targeted therapies can be developed. Our goal is to identify novel molecular focal points that control the multiple pathways that drive the pathogenesis of EOC. Many pathways that drive tumor pathogenesis are aberrations of processes that control normal embryonic development. We have found that the homeobox patterning gene DLX4 is not expressed in normal ovary and benign cysts, whereas its expression in malignant EOC is strongly associated with ascites, high tumor grade and advanced disease stage. Our studies of xenograft models demonstrated that DLX4 promotes EOC growth, dissemination, vascularization and ascites. We hypothesize that DLX4 is a molecular focal point that promotes the pathogenesis of EOC by inducing a pro-angiogenic, metastatic program. The goal of this proposal is to determine the mechanism by which DLX4 acts as a molecular switch to induce expression of effectors that drive EOC pathogenesis. Our specific aims are to determine: 1) the regulatory level at which DLX4 controls expression of key pro-angiogenic, metastatic factors 2) a novel regulatory mechanism by which DLX4 re-programs gene expression 3) the clinical significance and prognostic relevance of this re-programming mechanism In its tasks and implications, this proposal addresses the essential need for basic research of the biology of EOC. Moreover, in investigating novel regulatory mechanisms of a patterning gene in tumor pathogenesis, the study provides critical insight into how cancer is intimately related to embryonic development. PUBLIC HEALTH RELEVANCE: This proposal is directed to the study of epithelial ovarian cancer, a poorly-understood disease that is characterized by aggressive dissemination and is the fifth leading cause of female cancer death. We will study novel mechanisms by which deregulation of an embryonic patterning gene in epithelial ovarian cancer promotes tumor growth, dissemination, angiogenesis and ascites.